TAP Uprima
Executive Summary
Urology Subcommittee of FDA's Advisory Committee for Reproductive Health Drugs will discuss the Takeda/Abbott joint venture's apomorphine (NDA 21-118) for the treatment of erectile dysfunction April 10. The meeting will begin at 9 a.m. at the Holiday Inn in Bethesda, Md